IP vs NKTR · P/E 43, $26.62B cap vs rev $98.4M
International Paper (IP) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported NKTR revenue for 2024-12-31 was $98.4M. Net income was -$119.0M. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. NKTR currently screens at market cap $307.2M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the IP and NKTR stock pages for the full models.
Not investment advice.